Lukas Biomedical Inc Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Lukas Biomedical Inc

Watchlist Manager

Watchlist

Price: 18.05 TWD -4.5% Market Closed

Market Cap: NT$755.8m

L	Lukas Biomedical Inc TPEX:6814	TW
C	Comintel Corporation Bhd KLSE:COMCORP	MY
R	Real Asset Acquisition Corp NASDAQ:RAAQ	US

Profitability Summary

Lukas Biomedical Inc's profitability score is 8/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

59%

Strong 3Y Average Gross Margin

59%

Gross Margin is Increasing

56% > 59%

Negative Operating Margin

-52%

Negative 3Y Average Operating Margin

-38%

Declining Operating Margin

-17% > -52%

Negative Net Margin

-53%

Negative 3Y Average Net Margin

-39%

Declining Net Margin

-18% > -53%

Negative Free Cash Flow Margin

-49%

Negative 3Y Average Free Cash Flow Margin

-29%

Declining Free Cash Flow Margin

-3% > -49%

Negative ROE

-29%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-18%

Declining ROIC

-8% > -23%

View All

Hide

Collapse

8 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.